Healthcare provider profile · identity verified

Amardeep Kaur Gill, MD

Internal Medicine · TACOMA, WA · NPI 1679675888

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	693	208
Levothyroxine Sodium	Levothyroxine Sodium	349	83
Amlodipine Besylate	Amlodipine Besylate	326	94
Gabapentin	Gabapentin	309	77
Lisinopril	Lisinopril	261	74
Losartan Potassium	Losartan Potassium	228	66
Omeprazole	Omeprazole	208	64
Metformin Hcl	Metformin Hcl	152	41
Albuterol Sulfate Hfa	Albuterol Sulfate	140	54
Hydrochlorothiazide	Hydrochlorothiazide	134	39
Metoprolol Tartrate	Metoprolol Tartrate	131	37
Alendronate Sodium	Alendronate Sodium	129	37
Pantoprazole Sodium	Pantoprazole Sodium	125	33
Tizanidine Hcl	Tizanidine Hcl	121	42
Trazodone Hcl	Trazodone Hcl	115	28
Duloxetine Hcl	Duloxetine Hcl	111	25
Sertraline Hcl	Sertraline Hcl	110	30
Metoprolol Succinate	Metoprolol Succinate	109	33
Tramadol Hcl	Tramadol Hcl	109	28
Rosuvastatin Calcium	Rosuvastatin Calcium	107	33
Fluticasone Propionate	Fluticasone Propionate	103	55
Ozempic	Semaglutide	102	23
Metformin Hcl Er	Metformin Hcl	101	29
Montelukast Sodium	Montelukast Sodium	101	21
Potassium Chloride	Potassium Chloride	100	24
Simvastatin	Simvastatin	98	33
Furosemide	Furosemide	89	19
Carvedilol	Carvedilol	85	27
Clopidogrel	Clopidogrel Bisulfate	84	19
Jardiance	Empagliflozin	80	26
Famotidine	Famotidine	78	20
Tamsulosin Hcl	Tamsulosin Hcl	78	20
Venlafaxine Hcl Er	Venlafaxine Hcl	78	13
Buspirone Hcl	Buspirone Hcl	66	14
Hydralazine Hcl	Hydralazine Hcl	56	11
Pravastatin Sodium	Pravastatin Sodium	56	18
Methocarbamol	Methocarbamol	55	18
Estradiol	Estradiol	54	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	53	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	53	13
Allopurinol	Allopurinol	49	17
Cephalexin	Cephalexin	49	29
Citalopram Hbr	Citalopram Hydrobromide	49	15
Escitalopram Oxalate	Escitalopram Oxalate	49	12
Eliquis	Apixaban	48	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	48	suppressed
Spiriva Handihaler	Tiotropium Bromide	48	11
Trulicity	Dulaglutide	48	suppressed
Ezetimibe	Ezetimibe	47	18
Meloxicam	Meloxicam	47	suppressed
Bupropion Xl	Bupropion Hcl	46	16
Fluoxetine Hcl	Fluoxetine Hcl	46	14
Xarelto	Rivaroxaban	45	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	44	11
Clonidine Hcl	Clonidine Hcl	44	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	44	24
Synthroid	Levothyroxine Sodium	44	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	39	suppressed
Pregabalin	Pregabalin	38	suppressed
Lidocaine	Lidocaine	37	19
Mirtazapine	Mirtazapine	37	suppressed
Atenolol	Atenolol	36	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	13
Memantine Hcl	Memantine Hcl	33	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	32	suppressed
Mounjaro	Tirzepatide	32	suppressed
Ondansetron Odt	Ondansetron	32	16
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Aripiprazole	Aripiprazole	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Nifedipine Er	Nifedipine	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Glipizide	Glipizide	29	suppressed
Nystatin	Nystatin	29	17
Acetaminophen-Codeine	Acetaminophen With Codeine	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Lovastatin	Lovastatin	28	suppressed
Oxycodone Hcl	Oxycodone Hcl	28	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	28	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	21
Donepezil Hcl	Donepezil Hcl	24	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Spironolactone	Spironolactone	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Hydrocortisone	Hydrocortisone	21	suppressed
Incruse Ellipta	Umeclidinium Bromide	21	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	19	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Methadone Hcl	Methadone Hcl	19	suppressed
Methylprednisolone	Methylprednisolone	19	18
Alprazolam	Alprazolam	18	suppressed
Azithromycin	Azithromycin	18	18
Meclizine Hcl	Meclizine Hcl	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Telmisartan	Telmisartan	17	suppressed
Baclofen	Baclofen	16	suppressed
Finasteride	Finasteride	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Torsemide	Torsemide	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Fluconazole	Fluconazole	14	12
Irbesartan	Irbesartan	14	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Unifine Pentips	Pen Needle, Diabetic	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Levoxyl	Levothyroxine Sodium	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Prednisone	Prednisone	12	11
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Epinephrine	Epinephrine	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Olanzapine Odt	Olanzapine	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error